Skip to main content
. 2013 Jul;15(7):749–760. doi: 10.1593/neo.121956

Table 1.

Summary Data for Tissue Specimens on Progression Array.

Benign Malignant
Gender
M n = 38 (88.4%) n = 102 (81.0%)
F n = 5 (11.6%) n = 24 (19.0%)
Age 54.5 years (17–73 years) 60.7 years (25–85 years)
Grade
1 N/A n = 33 (26.2%)
2 N/A n = 58 (46.0%)
3 N/A n = 35 (27.8%)
Stage
T1 N/A n = 65 (38.5%)
T2 N/A n = 38 (22.5%)
T3 N/A n = 20 (11.8%)
T4 N/A n = 3 (1.8%)
Pathology Inflammation, n = 24 (55.8%) UC, n = 125 (99.2%)
Hyperplasia, n = 11 (25.6%) Undifferentiated carcinoma, n = 1 (0.8%)
Normal, n = 6 (14.0%)
Pheochromocytoma, n = 2 (5.7%)